SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001240015-04-000006
Filing Date
2004-07-20
Accepted
2004-07-20 13:32:19
Documents
1
Period of Report
2004-07-09

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 3842
  Complete submission text file 0001240015-04-000006.txt   5579
Mailing Address 25861 INDUSTRIAL BLVD HAYWARD CA 94545
Business Address 25861 INDUSTRIAL BLVD HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Issuer) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address 25861 INDUSTRIAL BLVD. HAYWARD CA 94545
Business Address 510-670-9300
Schramke Mary L. (Reporting) CIK: 0001296766 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-22570 | Film No.: 04921729